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Individual modules of modular polyketide syn-
thases (PKSs) such as 6-deoxyerythronolide B
synthase (DEBS) consist of conserved, cova-
lently linked domains separated by uncon-
served intervening linker sequences. To better
understand the protein-protein and enzyme-
substrate interactions in modular catalysis, we
have exploited recent structural insights to pre-
pare stand-alone domains of selected DEBS
modules. When combined in vitro, ketosyn-
thase (KS), acyl transferase (AT), and acyl car-
rier protein (ACP) domains of DEBS module 3
catalyzed methylmalonyl transfer and diketide
substrate elongation. When added to a minimal
PKS, ketoreductase domains from DEBS mod-
ules 1, 2, and 6 showed specificity for the b-
ketoacylthioester substrate, but not for either
the ACP domain carrying the polyketide sub-
strate or the KS domain that synthesized the
substrate. With insights into catalytic efficiency
and specificity of PKSmodules, our results pro-
vide guidelines for constructing optimal hybrid
PKS systems.
INTRODUCTION
Modular polyketide synthases (PKSs) are multifunctional
enzymes that catalyze the production of polyketide com-
pounds, many of which exhibit antibiotic, antifungal, anti-
cancer, and other important biological activities [1–5].
Each PKS module contains minimally three functional
domains—b-ketosynthase (KS), acyl transferase (AT),
and acyl carrier protein (ACP)—and a subset of tailoring
domains drawn from enzymes such as ketoreductases,
dehydratases, enoylreductases, and methyltransferases.
Together, the KS, AT, and ACP of a module catalyze decar-
boxylative condensation between the incoming polyketide
chain and a substituted malonyl thioester, while the tailor-
ing domains dictate the final oxidation state of theb carbon
(Figure 1). The modular architecture of polyketide syn-784 Chemistry & Biology 14, 784–792, July 2007 ª2007 Elseviethases has motivated numerous efforts toward combina-
torial biosynthesis of novel polyketides [6–11]. Genetic
manipulations including insertion, deletion, and substitu-
tion of domains or modules have allowed the generation
of a variety of polyketide analogs, with varying degrees
of success. Nonetheless, limited understanding of do-
main-domain compatibility, as well as lack of precise infor-
mation about domain boundaries, has thus far hampered
our ability to fully harness the power of biosynthetic
engineering.
6-deoxyerythronolide B synthase (DEBS) from Saccha-
ropolyspora erythraea is the most extensively studied
modular PKS. Organized into three homodimeric polypep-
tides, DEBS consists of six catalytic modules, each con-
taining a unique set of covalently linked catalytic domains.
Together, the six modules of this megasynthase produce
6-deoxyerythronolide B (6-dEB), the macrolide aglycone
core of the antibiotic erythromycin (Figure 1) [12, 13]. Be-
cause all modules of DEBS are comprised of combinations
of covalently fused domains in which individual domains
occur in equal molar ratios, we have sought to reconstitute
PKS activity by recombining individually expressed do-
mains (Figure 2A) [14, 15]. Prototypical versions of each
PKS fragment, whose boundaries were originally defined
by limited proteolysis, have now been characterized by
high-resolution structural studies [16, 17]. The dissection
and subsequent reconstitution of a functional module
from its constituent domains not only represent an excel-
lent strategy for defining authentic domain boundaries, it
also provides a route to interrogate domain-domain spec-
ificity within PKS modules. Here we report the reconstitu-
tion of fragmented, fully active PKS modules from isolated
recombinant domains (Figures 2B and 2C). A series of
assays was developed to monitor domain acylation, poly-
ketide chain elongation, and b-ketoacylthioester reduc-
tion. The knowledge gained from this study is expected
to strengthen the basis for the rational construction of
future generations of hybrid PKSs.
RESULTS
The previously characterized DEBS module 3 was chosen
as a target for the development and analysis of a fully
dissected PKS module [14, 15, 18]. Because ther Ltd All rights reserved
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(A) Modular organization of 6-deoxyerythronolide B synthase (DEBS). Chain elongation occurs minimally through the combined action of the
b-ketosynthase (KS), acyl transferase (AT), and acyl carrier protein (ACP) domains. Optional tailoring domains including ketoreductase (KR),
dehydratase (DH), and enoylreductase (ER) domains control the ultimate oxidation state of the b carbon. Once processed, the polyketide chain is
either passed to the KS domain of the downstream module or cyclized and released by the thioesterase (TE) domain at the C terminus of the
polyketide synthase. LDD, loading didomain.
(B) Chain elongation cycle catalyzed by DEBS module 3 + TE. AT is acylated with a methylmalonyl extender unit from its CoA derivative, which is then
transferred to the phosphopantetheine arm of the ACP domain. KS is primed with a 2-methyl-3-hydroxy pentanoyl unit from diketide 1. Once both the
growing chain and the extender units are covalently loaded onto the module, KS-mediated decarboxylative condensation occurs to form triketide
b-ketoacyl-ACP intermediate 2 with the release of carbon dioxide. TE catalyzes the release of the final triketide ketolactone product 3.ketoreductase domain from this module is inactive, the
ketoreductase domain from DEBS modules 1, 2, and 6
were targeted in this study. As a point of comparison,
we used DEBS module 6, whose domain organization is
similar that of DEBS module 3.Chemistry & Biology 14,Expression and Purification of Recombinant
KS and AT Domains from DEBS Module 3
Previous attempts to express isolated KS and AT domains
derived from modular PKSs have resulted in formation of
insoluble proteins. For AT domains, this problem was784–792, July 2007 ª2007 Elsevier Ltd All rights reserved 785
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Dissociation of a Type I PKS ModuleFigure 2. Fragmented Module Systems
(A and B) Chain elongation performed by (A)
[KS][AT] didomain and stand-alone ACP,
and (B) stand-alone KS, AT, and ACP.
(C) Reduction performed by stand-alone KR to
produce product 4.originally circumvented by expressing a chimeric AT-ACP
didomain construct [19]. Although this hybrid construct
facilitated analysis of the properties of individual AT do-
mains, its utility was limited due to the presence of the
fused ACP domain.
Based on a careful analysis of two recently solved
structures of the [KS3][AT3] and [KS5][AT5] didomains,
we have now constructed recombinant KS3 and two
versions of recombinant AT3, all three of which have
been expressed as soluble proteins. An EEAPERE se-
quence, which immediately follows the KS3 domain [17],
was identified as the junction site between KS3 and the
newly recognized KS-to-AT linker. The two distinct AT3
constructs were prepared to examine the role of the C-
terminal post-AT linker (30 residues from FALP to LAYR),
which wraps around both the AT3 domain and the KS-
to-AT linker and interacts with KS3 [17]. The smaller AT
protein, designated AT3(0), lacked the C-terminal post-
AT linker peptide, while the larger version, designated
AT3(3), included the complete post-AT linker region.
Both proteins retained the complete KS-to-AT linker at
their N termini, which was missing or incomplete in the
previously attempted insoluble and/or inactive AT con-
structs (data not shown). KS3 and AT3(0) were both ex-
pressed as soluble proteins at a yield of 10 mg purified
protein per liter culture, while AT3(3) was obtained in
a yield of 3 mg purified protein per liter culture.786 Chemistry & Biology 14, 784–792, July 2007 ª2007 ElsevieAcylation and Transacylation of Recombinant
AT3 Domains
The AT domain of a DEBS module first captures the meth-
ylmalonyl-CoA extender unit to generate a covalent methyl-
malonyl-O-AT intermediate, and then transfers the methyl-
malonyl moiety to the phosphopantetheinyl side chain of
the ACP of the same module. To confirm the individual ac-
ylation and transacylation activities of recombinant AT3,
both with and without the post-AT linker region, AT3(0)
and AT3(3) were each incubated with [14C]methylmalonyl-
CoA, either alone or in the presence of ACP3. Radio-SDS-
PAGE analysis showed that both versions of AT3 were in-
deed acylated by methylmalonyl-CoA (Figure 3A, lanes 1
and 3) and each could also transfer the methylmalonyl
unit to the discrete ACP3 domain (Figure 3A, lanes 2 and
4). Thus, the post-AT linker is not required for either the
methylmalonylation or transacylation activity of the AT do-
main. Furthermore, when either AT3 protein was incubated
with [14C]malonyl-CoA, no protein labeling was observed
(data not shown), indicating that the isolated, recombinant
AT domain retained its intrinsic substrate specificity.
Acylation of the Recombinant KS3 Domain
In polyketide chain elongation by modular polyketide syn-
thases, the KS domain normally receives the growing pol-
yketide chain as an acyl thioester attached to the ACP do-
main of the upstream module. This ACP can be replacedr Ltd All rights reserved
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Acylation
(A) Acylation and transacylation activities of
isolated DEBS AT3. Radiolabeled methylma-
lonyl-CoA with AT3(3) (lane 1), AT3(3) + ACP3
(lane 2), AT3(0) (lane 3), and AT3(0) + ACP3
(lane 4).
(B) Acylation activities of isolated DEBS KS3.
Radiolabeled diketide 1 with KS3 (lane 1),
KS3 + AT3(3) (lane 2), and KS3 + AT3(0) (lane 3).by a surrogate N-acetylcysteamine thioester analog. To
evaluate the self-acylation activity of the discrete KS3
domain, the recombinant KS3 protein was incubated
with [14C]1, with or without added AT3(3) or AT3(0). Ra-
dio-SDS-PAGE showed that the isolated KS3 was indeed
acylated by diketide 1 (Figure 3B, lane 1) with comparable
occupancy of the active site relative to that of [KS3][AT3].
However, reduced KS acylation was observed at lower
ketide substrate concentration (50 mM; data not shown).
The presence of recombinant AT3, with or without the
post-AT linker, had no observable influence on KS3 acyl-
ation (Figure 3B, lanes 2 and 3).
Condensation Activity of the Fragmented
KS3 + AT3 + ACP3 System
Once the acylation activities of both KS3 and AT3 were
confirmed, we examined the condensation activity of the
dissociated system by incubating recombinant KS3 with
unlabeled 1, [14C]methylmalonyl-CoA, holo-ACP3, and
either AT3(3) or AT3(0). A radio-TLC assay was used to
detect the formation of triketide condensation products.
Surprisingly, whereas AT3(3) and AT3(0) had performed
similarly in self-methylmalonylation, the expected triketide
ketolactone 3was formed only in the presence of AT3(3) in
combination with KS3 and ACP3 (Figure 4). This result
indicates that the post-AT linker, while not necessary for
methylmalonylation of the discrete AT domain, is required
for KS-catalyzed b-ketoacyl-ACP synthase activity. Nota-
bly, the results summarized in Figure 4 also demonstrate
for the first time, to our knowledge, the feasibility of dis-
secting a type I PKS module into its constituent domains
and reconstituting the functions of the complete module
from a combination of the individual domains, analogous
to the operation of a typical type II PKS as a fully frag-
mented PKS.
Recombinant Ketoreductases
In addition to the KS, AT, and ACP domains, functional
ketoreductases (KRs) are present in five of the six DEBS
modules and have been expressed as isolated domains
[20]. To construct a fully fragmented system with b-ketor-
eduction activity, the KR domains from DEBS modules 1,
2, and 6 were each expressed as isolated, soluble pro-
teins, at a yield of 20 mg purified protein per liter culture.
To evaluate the catalytic activity of the individual re-
combinant KR domains, each KR protein was first testedChemistry & Biology 14,in combination with both the [KS3][AT3] didomain +
ACP3 and the [KS6][AT6] didomain + ACP6 systems. Fig-
ure 5 shows the activities of KR1, KR2, and KR6 toward tri-
ketide-S-ACP 2 in the module 3 (Figure 5A) and module 6
(Figure 5B) systems. The formation of the reduced b-
hydroxy triketide lactone product 4 established that both
KR2 and KR6 had comparable activity in both reconsti-
tuted PKS systems regardless of the KS-KR combination.
That is, KR2 reduced triketide 2 to give triketide lactone 4
exclusively regardless of whether the ACP-bound (2-D-
methyl)-triketide 2 was generated by KS3 or KS6. Simi-
larly, KR6 produced a mixture of unreduced triketide lac-
tone 3 and reduced triketide lactone 4 in both systems.
The stereochemistry of triketide lactone 4 is currently
Figure 4. Effect of the Post-AT Linker in Condensation
Radio-TLC/phosphorimaging assay for the formation of triketide keto-
lactone 3 by DEBS KS3 + AT3(3) + ACP3 (lane 1) and KS3 + AT3(0) +
ACP3 (lane 2). This result indicates that the post-AT linker is required
for KS-catalyzed b-ketoacyl-ACP synthase activity.784–792, July 2007 ª2007 Elsevier Ltd All rights reserved 787
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the Specificity of KR toward the Partner-
ing KS
DEBS KR1 (lane 1), KR2 (lane 2), and KR6 (lane
3) with [KS3][AT3] + ACP3 (A) or [KS6][AT6] +
ACP6 (B). In both module 3 and module 6 sys-
tems, KR1 produced no reduced product, KR2
produced the reduced product exclusively,
while KR6 produced a mixture of the reduced
and unreduced products. Radioactive intensi-
ties of the products are tabulated in Table S1.under investigation. It should be noted that ACP-bound
(2-D-methyl)-triketide 2, the product of condensation of
diketide 1 and methylmalonyl-CoA, is the natural sub-
strate for KR2. By contrast, KR1, which normally pro-
cesses a diketide, did not reduce the acyclic triketide 2
at all. As a control, the activity of recombinant KR1 was in-
dependently established using propionyl-SNAc as the
primer for KS1 (data not shown).
Because a KR domain normally reduces the condensa-
tion product that is tethered to the ACP of the same mod-
ule, a KR domain might be expected to have an intrinsic
specificity toward its cognate ACP domain compared to
heterologous ACP domains. To test this hypothesis, KR2
was incubated with [KS3][AT3] and a panel of six recombi-
nant DEBS ACP proteins from modules 1–6 (Figure 6A). By
varying the ACP protein partner while holding the [KS][AT]
protein and substrates constant, we were able to probe
the effect of KR-ACP interaction on the efficiency of re-
duction, as measured by the effect on the ratio of reduced
to unreduced triketide lactones 4 and 3. The results
suggest that KR2 does not discriminate among the six
DEBS ACPs, with reduced triketide lactone 4 being the ex-
clusive product in all cases. By contrast, as we have pre-
viously reported, the KS3 and KS6 domains each have788 Chemistry & Biology 14, 784–792, July 2007 ª2007 Elseviea marked preference for a distinct subset of ACP partners
[15]. For example, KS3 carries out condensation most ef-
ficiently in combination with ACP3 or ACP5, relatively well
with ACP2 or ACP4, and poorly with ACP1 or ACP6. The
inclusion of the recombinant KR domains did not alter
the relative kcat profile for generation of triketide, suggest-
ing that KR does not perturb the rate of condensation and
that any sensitivity to the identity of the ACP domain has
no observable effect on the overall rate of formation of re-
duced triketide (see Table S2 in the Supplemental Data
available with this article online). Analogous results were
obtained when KR6 was incubated with [KS6][AT6] and
the same panel of six DEBS ACP proteins, with a compa-
rable proportion of reduced and unreduced triketide lac-
tones being formed independently of the origin of the
ACP domain (Figure 6B).
Together, the above results suggest that ketoreductase
domains have specificity for the structure of their polyke-
tide substrates but are not sensitive to either the ACP
domain to which these substrates are anchored or to the
KS domain that generates the b-ketoacyl-ACP intermedi-
ate. We have further established (e.g., Figure 7) that DEBS
modules can be completely dissected into their constitu-
ent catalytic protein domains that retain their intrinsicFigure 6. Radio-TLC Assay to Examine the Specificity of KR toward the Partnering ACP
DEBS ACP1–6 (lanes 1–6, respectively) with [KS3][AT3] + KR2 (A) or [KS6][AT6] + KR6 (B). Regardless of the ACP partner, KR2 produced the reduced
product almost exclusively, while KR6 produced a mixture of the reduced and unreduced products. Radioactive intensities of the products are tab-
ulated and compared to the kcat profiles in Table S2.r Ltd All rights reserved
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gous domain partners.
DISCUSSION
In a type I PKS module, substrates and intermediates are
channeled through a defined sequence of domain acyla-
tion, chain elongation, polyketide reduction, and polyke-
tide transfer reactions. Although this intramodular organi-
zation ensures that complex polyketide biosynthesis
takes place with high fidelity, it presents considerable bar-
riers to detailed mechanistic studies of individual reaction
steps catalyzed by each PKS domain. By separating the
constituent domains of a single PKS module, we can
now investigate the contribution of each domain to sub-
strate specificity, catalytic activity, stereocontrol, and
interdomain interactions, as well as their combined contri-
bution to overall polyketide biosynthesis. A better under-
standing of the actual domain boundaries is essential to
the rational and efficient engineering of hybrid PKS sys-
tems. Previous studies have firmly identified the YRVXW
cleavage site between the acyl transferase and ketore-
ductase domains as well as the RLAGL site between
ketoreductase and acyl carrier protein domains [14, 15].
We have now utilized a third domain boundary site to con-
struct discrete, soluble recombinant KS and AT domains.
We have also discovered unexpected properties of the
interdomain linkers, explored the substrate and protein
Figure 7. Condensation Performed by the Fully Fragmented
Systems
Radio-TLC assay for the formation of triketide lactones 3 and 4 by the
fully fragmented systems. DEBS KS3 + AT3(3) with no KR (lane 1), KR2
(lane 2), or KR6 (lane 3). Radioactive intensities of the products are
tabulated in Table S3.Chemistry & Biology 14,specificity of KR domains, and reconstituted the activity
of a PKS module from isolated recombinant domains.
Acyl Transferase Domain
The AT domain of a given module determines the extender
unit, normally methylmalonyl or malonyl, that is incor-
porated into the final polyketide chain. To introduce non-
cognate extender units, previous studies have utilized AT
domain swaps, but many of the resulting hybrid modules
suffer from a significant kinetic penalty, presumably due
to the introduction of suboptimal inter- or intradomain
junctions or inefficient interdomain interactions [21–26].
To unambiguously establish the proper AT domain bound-
aries, two versions of the recombinant AT from DEBS mod-
ule 3 were constructed, based on a detailed analysis of the
X-ray crystal structures of the [KS3][AT3] and [KS5][AT5]
didomains. One such construct, AT3(3), contained the
C-terminal post-AT linker; the other lacked this linker and
was designated AT3(0). Both proteins, which retain the
100 amino acid KS-to-AT linker at their respective N
termini, were soluble and active in both self-catalyzed
methylmalonylation and AT/ACP transacylation assays.
They also retained their characteristic strict intrinsic
substrate specificity toward methylmalonyl-CoA. These
results, which represent the first successful expression,
to our knowledge, of a stand-alone, soluble AT domain, es-
tablish that the globular portion of the AT3 domain is struc-
turally stable, catalytically active, and substrate specific.
Ketosynthase Domain and the Effect
of the Post-AT Linker
To catalyze polyketide chain elongation, a KS domain first
forms a covalent acyl-enzyme intermediate between the
growing polyketide chain and the thiol of its active site
Cys before catalyzing decarboxylative condensation
with the methylmalonyl-ACP or malonyl-ACP cosub-
strate. To develop a fully fragmented PKS system, the re-
combinant KS domain of DEBS module 3 was dissected
from the downstream AT domain at the EEAPERE junction
site, based on an analysis of the [KS3][AT3] and
[KS5][AT5] didomain structures [16, 17]. Both the high
level of protein expression and the results of incubation
experiments with diketide 1 confirmed the structural sta-
bility and intact self-acylation activity of the resulting re-
combinant KS3 domain. Successful chain elongation in
the presence of AT3(3) and ACP3 further confirmed that
the recombinant KS3 domain retained condensation ac-
tivity and demonstrated the feasibility of reconstituting
polyketide synthase activity from disconnected PKS do-
mains. The absence of detectable chain elongation activ-
ity using AT3(0) as a reaction partner, however, revealed
the importance of the post-AT linker in allowing KS-
ACP-catalyzed condensation. Models of the docking
between the [KS3][AT3] didomain and a discrete ACP pro-
tein provide the mechanistic rationale for these observa-
tions: when the ACP interacts with the KS domain, it
docks in a deep groove formed by the interaction of the
KS, AT, and the post-AT linker, thereby implicating
both the AT and the post-AT linker in functional KS-ACP784–792, July 2007 ª2007 Elsevier Ltd All rights reserved 789
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ciation of the KS and AT domains is therefore a likely
prerequisite to effective binding of the nucleophilic
methylmalonyl-ACP cosubstrate. In fact, we observed a
greater than 1000-fold reduction in the observed rate of
triketide production by the reconstituted [KS3] + [AT3]
system relative to the intact [KS][AT] didomain (data not
shown). The structures of the [KS][AT] didomains, along
with the results of the biochemical assays, also suggest
that the post-AT linker is an intrinsic component of a func-
tional KS domain. This noncontiguity between the primary
PKS sequence and three-dimensional domain boundaries
presents additional challenges to efficient PKS domain
swaps.
Ketoreductase Domains
Recent studies on recombinant KR domains have pro-
vided valuable insights into both protein structure and
reaction stereospecificity [8, 20, 27–31]. Until now, how-
ever, protein-protein recognition by individual KS-KR
and KR-ACP pairs has been essentially unexplored. We
have reported here the lack of discrimination of both
DEBS KR2 and KR6 between their cognate and noncog-
nate KS and ACP domains in experiments using discrete
[KS][AT] didomains, stand-alone recombinant KR do-
mains, and stand-alone ACP domains. Although it is per-
haps not surprising that both KR2 and KR6 are insensitive
to the structure of their KS partners (as no direct contact
between the KS and KR domains should be required for
KR-catalyzed reduction), the lack of specificity for the
ACP is somewhat unexpected. These results suggest
that the phosphopantetheinyl arm is adequate for sub-
strate recognition by the KR, although it has been inde-
pendently reported that reduction stereospecificity may
be seriously degraded when the ACP thioester is replaced
by the commonly used N-acetylcysteamine analog [20].
The possibility of combining KR domains with both KS
and ACP domains from different modules provides the op-
portunity for engineering catalytically efficient hybrid PKS
modules, as long as the intrinsic substrate specificity of
heterologous KR domains can be appropriately taken
into consideration. Coupled with the previous studies on
AT-ACP and KS-ACP specificities, it appears that the
KS-ACP pairing is the most specific of all protein-protein
interactions in the PKS assembly line. Armed with this in-
formation, it should be possible to avoid severe kinetic
penalties in engineered hybrid PKS modules by maximiz-
ing constituent KS-ACP interdomain compatibility.
Improperly chosen domain boundaries as well as the
intrinsic incompatibility of the component domains are
major barriers to rational engineering of PKS modules.
By dissecting a PKS module into its constituent domains,
we have identified a set of domain junction sites that yield
stable and functional domains, have determined domain-
domain compatibilities, and have demonstrated the feasi-
bility of reconstituting modular activities from combina-
tions of isolated, recombinant domains. This ‘‘divide and
conquer’’ approach also provides the toolbox to investi-
gate detailed reaction mechanisms, substrate specificity,790 Chemistry & Biology 14, 784–792, July 2007 ª2007 Elsevierand stereocontrol that is not possible using far more com-
plex, intact PKS modules. By adding more functional
domains to this biomolecular toolbox, it should be possi-
ble to effect practical combinatorial biosynthesis of novel
polyketides and polyketide precursors suitable for further
synthetic modification.
SIGNIFICANCE
Modular polyketide synthases are well known for their
complexity, a feature that prevents detailed mecha-
nistic studies of the individual reaction steps cata-
lyzed by each domain. Here we report the dissection
and reconstitution of a fully active PKSmodule that re-
tains all the intrinsic catalytic activities of its constitu-
ent domains. This experimental approach not only
confirms that authentic domain boundaries can be
used as effective handles for protein engineering, it
also allows us to investigate the contribution of each
domain to substrate specificity, catalytic activity, re-
action kinetics, stereocontrol, and interdomain inter-
actions. With insights provided by fragmented PKS
modular systems, we can now avoid the introduction
of suboptimal inter- or intradomain junctions and un-
productive interdomain interactions, and in so doing,
improve the rational design of efficient hybrid PKS
systems for biosynthesis of novel polyketides.
EXPERIMENTAL PROCEDURES
Reagents and Chemicals
DL-[2-methyl-14C]methylmalonyl-CoA was from American Radiola-
beled Chemicals. [14C](2S,3R)-2-methyl-3-hydroxypentanoyl-N-
acetylcysteamine thioester (1) was prepared by custom synthesis by
Amersham Pharmacia. Unlabeled diketide 1 was prepared by estab-
lished methods [32–34]. All other chemicals were from Sigma. Thin-
layer chromatography (TLC) plates were from J.T. Baker. SDS-PAGE
gradient gels (4%–15% acrylamide) were from Bio-Rad. Ni-NTA affin-
ity resin was from QIAGEN. HiTrap-Q anion-exchange column was
from Amersham Pharmacia.
Cloning and Expression of KS, AT, and KR Domains from DEBS
The DNA sequence encoding DEBS KS3 was amplified by PCR as an
NdeI-EcoRI fragment using primers 50-AAAAAAACATATGGTGACTG
ACAGCGAGAAGG-30 and 50-TTTTGAATTCACAGGAGCTTCCTCGAC
GATCAC-30. This NdeI-EcoRI fragment was cloned into the pET21 ex-
pression vector to yield plasmid pAYC48, encoding DEBS KS3 with the
N-terminal linker and a C-terminal His6 tag. The DNA sequence encod-
ing DEBS AT3 with the post-AT linker (denoted AT3[3]) was con-
structed similarly into pET21 with primers 50-CGAGGAACATATGGAG
CGCGAGCACCGGGAGACC-30 and 50-CGGAGTCGAATTCACGCG
GTAGGCCAGCTCGTCGG-30 to yield plasmid pAYC23. The DNA
sequence encoding DEBS AT3 without the post-AT linker (denoted
AT3[0]) was amplified and introduced into pET21 with primers 50-CGA
GGAACATATGGAGCGCGAGCACCGGGAGACC-30 and 50-TTTTGA
ATTCACGGGCGCGGCGCCGGGCAGAGC-30 to yield plasmid pAYC47.
The DNA sequence encoding DEBS KR1 was amplified and intro-
duced into the pET28 expression vector with primers 50-AAAAAACATA
TGGACGAGGTTTCCGCGCTGCGC-30 and 50-TTTTGAATTCACCG
CGCCCACCCGCGGTTCGGC-30 to yield plasmid pAYC59. The DNA
sequence encoding DEBS KR2 was amplified and introduced into
pET28 with primers 50-AAAAAACATATGGACGAGCTCGACGGCTG
GTTC-30 and 50-TTTTGAATTCACCCGGTCGCGCAGGCTCTCCGTC-30Ltd All rights reserved
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was amplified and introduced into pET28 with primers 50-AAAAA
CATATGGCCGACAGCCGCTACCGCGTCG-30 and 50-TTTTTTGAATT
CACCGTCATCTCCCGCGCCGGG-30 to yield plasmid pAYC62. All
six plasmids were transformed into Escherichia coli BL21 for protein
expression. Proteins were expressed and purified using the previously
described protocol [15].
The expression and purification of the [KS][AT] didomains from
DEBS module 3 (pAYC02) and module 6 (pAYC10) and the ACP do-
mains from all six DEBS modules have been previously described [15].
Acylation of Recombinant AT3 by [14C]Methylmalonyl-CoA
AT3(3) or AT3(0) (20 mM, in 100 mM phosphate [pH 7.2]) alone or
together with holo-ACP3 (100 mM) was incubated on ice with 20 mM
[14C]methylmalonyl-CoA and 5 mM tris-2-carboxyethyl-phosphine
(TCEP) for 10 min. Samples were quenched with SDS-PAGE loading
buffer lacking any reducing agents and loaded directly onto an SDS-
PAGE gel. The gel was dried using a Bio-Rad gel-drying system and
analyzed using a phosphorimager.
Acylation of Recombinant KS3 by [14C]Diketide 1
KS3 (20 mM, in 100 mM phosphate [pH 7.2]) alone or together with
AT3(3) or AT3(0) (20 mM) was incubated with 1 mM [14C]1 and 5 mM
TCEP for 90 min at room temperature. Samples were quenched and
processed as described above.
Triketide Lactone Formation
The reaction volume was 10 ml for all single time point assays. KS3 +
AT3 + ACP3 system (Figure 4): KS3 (10 mM, in 100 mM phosphate
[pH 7.2]) was incubated with 10 mM AT3(3) or AT3(0), 10 mM unlabeled
diketide 1, and 5 mM TCEP for 1 hr at room temperature to acylate the
KS domain to completion. Holo-ACP3 (150 mM) and 150 mM DL-
[2-methyl-14C]methylmalonyl-CoA were then added and allowed to
react at room temperature for an additional hour. The reaction was
quenched by adding 20 ml of 0.5 M potassium hydroxide and heating
the mixture for 20 min at 65C. Hydrochloric acid (10 ml of 1.5 M)
was then added, and the mixture was dried in a speedvac for 2 hr.
The pellet was resuspended in 10 ml of ethyl acetate and spotted
onto a TLC plate. A 60:40 mixture of ethyl acetate:hexane was used
for TLC, and the radiolabeled products were then visualized and quan-
tified using a Packard phosphorimager. [KS][AT] + KR + ACP system
(Figures 5 and 6): [KS3][AT3] or [KS6][AT6] (10 mM, in 100 mM phos-
phate [pH 7.2]) was incubated with 5 mM diketide 1 and 5 mM TCEP
for 1 hr at room temperature to acylate KS to completion. KR
(150 mM), holo-ACP (150 mM), 2 mM NADPH, and 150 mM DL-[2-
methyl-14C]methylmalonyl-CoA were then added and allowed to react
at room temperature for an additional hour. The reactions were
quenched and analyzed as described above. KS + AT + KR + ACP
system (Figure 7): KS3 (10 mM, in 100 mM phosphate [pH 7.2]) was in-
cubated with 10 mM AT3(3), 10 mM unlabeled compound 1, and 5 mM
TCEP for 1 hr at room temperature to acylate KS to completion. KR
(150 mM), holo-ACP (150 mM), 2 mM NADPH, and 150 mM DL-[2-
methyl-14C]methylmalonyl-CoA were then added and allowed to react
at room temperature for an additional hour. The reactions were
quenched and analyzed as described above.
Supplemental Data
Supplemental Data include three tables and can be found with this
article online at http://www.chembiol.com/cgi/content/full/14/7/784/
DC1/.
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